Douglas Fox
Impact in
- Structural Biology top 10%
- Infectious Diseases top 10%
- Tuberculosis Research and Epidemiology
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Tuberculosis Research and Epidemiology 4
- SARS-CoV-2 and COVID-19 Research 2
- SARS-CoV-2 detection and testing 1
-
- Glycosylation and Glycoproteins Research 1
- Co-authors
- Carolyn R. Bertozzi (4 shared papers)Benjamin M. Swarts (2 shared papers)M. Sloan Siegrist (2 shared papers)Sarah A. Stanley (6 shared papers)Shion A. Lim (1 shared paper)Rainer Kalscheuer (1 shared paper)John C. Jewett (1 shared paper)Julie A. Leary (1 shared paper)
- Journals
- PLoS Pathogens (2 papers)Antimicrobial Agents and Chemotherapy (1 paper)The Journal of Immunology (1 paper)BioEssays (1 paper)PLoS Biology (1 paper)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Douglas Fox
11 papers receiving 643 citations
Peers
Comparison fields: 5 of 85
- Structural Biology 20
- Infectious Diseases 198
- Organic Chemistry 151
- Molecular Biology 346
- Molecular Medicine 20
Countries citing papers authored by Douglas Fox
This map shows the geographic impact of Douglas Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Fox more than expected).
Fields of papers citing papers by Douglas Fox
This network shows the impact of papers produced by Douglas Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Fox. The network helps show where Douglas Fox may publish in the future.
Co-authors
The 25 scholars most cited alongside Douglas Fox, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 158 | |
| 2 | 2021 | 112 | |
| 3 | 2015 | 111 | |
| 4 | 2020 | 82 | |
| 5 | 2012 | 44 | |
| 6 | 2022 | 41 | |
| 7 | 2022 | 33 | |
| 8 | 2022 | 22 | |
| 9 | 1999 | 21 | |
| 10 | 2021 | 17 | |
| 11 | 2017 | 12 | |
| 12 | 2025 | 0 |
About Douglas Fox
Douglas Fox is a scholar working on Infectious Diseases, Molecular Biology, Epidemiology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 12 papers that have together received 653 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (4 papers), Mycobacterium research and diagnosis (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (1 paper), Click Chemistry and Applications (1 paper), Glycosylation and Glycoproteins Research (1 paper) and SARS-CoV-2 detection and testing (1 paper). The work is most often cited by research in Structural Biology (20 citations), Infectious Diseases (198 citations), Organic Chemistry (151 citations), Molecular Biology (346 citations) and Molecular Medicine (20 citations). Douglas Fox has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Carolyn R. Bertozzi, Benjamin M. Swarts, M. Sloan Siegrist, Sarah A. Stanley, Shion A. Lim, Rainer Kalscheuer, John C. Jewett, Julie A. Leary, Cynthia M. Holsclaw and W. Wayt Gibbs. Their work appears in journals such as PLoS Pathogens, Antimicrobial Agents and Chemotherapy, The Journal of Immunology, BioEssays and PLoS Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.